Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
LIOTHYRONINE SODIUM
Mercury Pharma Group Ltd
H03AA; H03AA02
LIOTHYRONINE SODIUM
20 microgram(s)
Powder for solution for injection
Product subject to prescription which may not be renewed (A)
Thyroid hormones; liothyronine sodium
Not marketed
1993-10-19
PACKAGE LEAFLET: INFORMATION FOR THE USER TRIIODOTHYRONINE 20 MICROGRAMS POWDER FOR SOLUTION FOR INJECTION Liothyronine sodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU HAVE THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor,pharmacist or nurse. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Triiodothyronine injection is and what it is used for 2. What you need to know before you are given Triiodothyronine injection 3. How Triiodothyronine injection is given 4. Possible side effects 5. How to store Triiodothyronine injection 6. Contents of the pack and other information 1. WHAT TRIIODOTHYRONINE INJECTION IS AND WHAT IT IS USED FOR Triiodothyronine injection contains liothyronine sodium which is a quick acting, naturally occurring form of the hormone thyroxine. Thyroxine is normally produced by the thyroid gland in the neck. It controls many bodily functions, mainly to do with growth and energy. Triiodothyronine injection is used to treat severe underactivity of the thyroid gland (myxoedema coma) when it is not possible to give thyroid treatment by mouth. It may be used with other medicines such as steroids. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN TRIIODOTHYRONINE INJECTION DO NOT TAKE TRIIODOTHYRONINE INJECTION IF: • you know that you are allergic to liothyronine sodium or any of the other ingredients of Triiodothyronine injection (see section 6 of this leaflet) • you have a disease involving the heart or blood vessels. • you have pain in the chest (angina pectoris) • you have an overactive thyroid gland with raised levels of thyroid hormones (thyrotoxicosis). Please tell your doctor before you are given this injection if any of the above applies to you. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Triiodothyronine injection if you: • suffer from diabetes. The dosa Preberite celoten dokument
Health Products Regulatory Authority 22 March 2019 CRN008MKD Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Triiodothyronine 20 Micrograms Powder for Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 20 micrograms liothyronine sodium Excipient(s) with known effect For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection. White, freeze-dried powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS It is indicated for the treatment of myxoedema coma, usually in conjunction with other measures including the intravenous injection of a corticosteroid. For the treatment of less severe forms of myxoedema and for maintenance therapy, orally administered liothyronine should be used. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Dosage: 5 to 20 micrograms given by slow intravenous injection and repeated at intervals of 12 hours or less if required. The minimal interval between dosing is 4 hours. An initial dose of 50 micrograms intravenously is used by some physicians, followed by further intravenous injections of 25 micrograms every 8 hours until improvement occurs. The dosage may then be reduced to 25 micrograms intravenously twice daily. Method of administration: Usually given by intravenous injection, as the alkalinity of the solution may cause irritation of the tissues if given by deep intramuscular injection. The solution is prepared by adding 1 or 2ml water for injection to the ampoule and shaking gently until the solution has dissolved. Geriatric patients –In elderly patients with severe long-standing hypothyroidism, treatment with liothyronine sodium should be introduced with doses at the low end of the range, with smaller increments and longer intervals between increases as necessary. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. Liothyronine sodium is contraindicated in patients with cardiovascular disorders or angina o Preberite celoten dokument